|
|||||
|
|
Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder |
|
| Authors: | Carlos A. Zarate Jr. |
| Affiliation: | 1.Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA |
| Abstract: | |
| Keywords: | ketamine major depressive disorder clinical practice guidelines |